Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia.

Current hematologic malignancy reports - 1 Oct 2021

Hammond Danielle, Montalban-Bravo Guillermo

Abstract excerpt

PURPOSE OF REVIEW: Despite recent advances in the treatment of de novo acute myeloid leukemia (AML), AML arising from antecedent chronic myelomonocytic leukemia (CMML) continues to have dismal outcomes. While the unique biological drivers of CMML and subsequent leukemic transformation (LT) have been revealed with advances in molecular characterization, this has not yet translated to the bedside. Here, we review...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Blast Crisis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bridged Bicyclo Compounds, Heterocyclic

Share to Disease Management

Share to Drug Discovery

Share to Leukemia, Myelomonocytic, Chronic

Share to Molecular Targeted Therapy

Share to Sulfonamides

Source

Identifiers

PMID: 34499330
DOI: 10.1007/s11899-021-00643-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia.PMID 34499330Read ↗

Evolving Understanding of Chronic Myelomonocytic Leukemia: Implications for Future Treatment Paradigms.Semantic proximity Read ↗

A Concise Update on Risk Factors, Therapy, and Outcome of Leukemic Transformation of Myeloproliferative Neoplasms.Semantic proximity Read ↗

Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.Semantic proximity Read ↗

Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification.Semantic proximity Read ↗

Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work?Semantic proximity Read ↗

How I diagnose and treat chronic myelomonocytic leukemia.Semantic proximity Read ↗

Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.Semantic proximity Read ↗

Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.Semantic proximity Read ↗

Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Acute Myeloid Leukemia Evolving from Myeloproliferative Neoplasms: Many Sides of a Challenging DiseaseSemantic proximity Read ↗

Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovationsSemantic proximity Read ↗

Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and managementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.